Gong, Yuqing
Hopefl, Robert
Li, Tonglei
Hooker, Andrew C.
Silva, Daniela Amaral
Alam, Khondoker
Ducharme, Murray
Moody, Rebecca
Saha, Pratik
Babiskin, Andrew https://orcid.org/0000-0001-9968-0197
Funding for this research was provided by:
U.S. Food and Drug Administration (U18FD007054)
U.S. Food and Drug Administration (HHSF223201710015C)
U.S. Food and Drug Administration (75F40119C10018)
U.S. Food and Drug Administration (75F40122C00139)
U.S. Food and Drug Administration (75F40121C00133)
Article History
Received: 2 December 2024
Accepted: 15 January 2025
First Online: 28 January 2025
Change Date: 14 February 2025
Change Type: Update
Change Details: The original online version of this article was revised: The original article has been updated to remove the incorrect reference citation "(Lachaine et al Can J Psychiatry. 60:S40-S47, 2015)” from the first sentence in the abstract. This error was introduced in production and was not the fault of the authors.
Change Date: 12 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11095-025-03832-4
Declarations
:
: The opinions expressed in this article are those of the authors and should not be construed to represent the views or policies of their affiliated organizations/agencies. ACH is a co-founder and an advisor to the pharmaceutical consulting company Pharmetheus AB.
: All other authors declared no competing interests for this work.